Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.31 trillion and total revenue of $119.74 billion.
Market Cap
1.31T
Revenue
119.74B
Profits
-34.05B
PE Ratio
n/a
Profit Margin
-28.44%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 142.27B | 3.94% | 86,931 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 90.97B | 11.26% | 232,256 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 88.94B | - | 889,564 | 2.23B |
| 4 | ARGX | argenx SE | 57.06B | 1.60% | 10,148 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 42.25B | - | 5,686 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.31B | -1.16% | 9,815 | - |
| 7 | RPRX | Royalty Pharma plc | 38.38B | 1.23% | 165,659 | 2.54B |
| 8 | GMAB | Genmab A/S | 34.82B | 2.99% | 265,182 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.38B | 1.01% | 140,929 | 7.53M |
| 10 | INSM | Insmed Incorporated | 24.90B | 2.16% | 97,170 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.57B | 3.77% | 75,184 | 6.01B |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 23.40B | 0.51% | 171,552 | 5.01B |
| 13 | BNTX | BioNTech SE | 22.31B | -0.35% | 15,999 | 3.03B |
| 14 | EXEL | Exelixis, Inc. | 17.01B | 3.72% | 126,663 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.62B | - | 3,439 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 15.10B | 1.39% | 19,676 | 1.66B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.47B | 4.62% | 79,768 | 945.54M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 13.65B | 1.15% | 6,739 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 13.07B | 0.86% | 95,813 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | -0.01% | 77,957 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.29B | 1.49% | 39,075 | 3.41B |
| 22 | TWST | Twist Bioscience Corporation | 10.29B | -5.41% | 85,676 | 431.80M |
| 23 | KYMR | Kymera Therapeutics, Inc. | 10.16B | -0.35% | 8,848 | 102.24M |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.97B | - | 1,902 | 1.28B |
| 25 | CAI | Caris Life Sciences, Inc. | 9.92B | -2.84% | 59,157 | 989.61M |
| 26 | PCVX | Vaxcyte, Inc. | 9.84B | -0.10% | 10,185 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 9.66B | 0.57% | 2,948 | 440.48M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 9.35B | 0.11% | 8,234 | 281.99M |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.31B | 0.23% | 12,514 | 830.81M |
| 30 | SYRE | Spyre Therapeutics, Inc. | 9.25B | - | 6,723 | - |
| 31 | IBRX | ImmunityBio, Inc. | 9.13B | -1.49% | 414,625 | 165.79M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.82B | 0.19% | 11,935 | 67.67M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.56B | 0.18% | 9,773 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 8.30B | 0.72% | 23,774 | 799.54M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.93B | -1.65% | 6,366 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.76B | -1.64% | 22,709 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.48B | -0.40% | 34,117 | 776.57M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.44B | 0.81% | 33,018 | 874.09M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.41B | - | 4,326 | 239.92M |
| 40 | KOD | Kodiak Sciences Inc. | 6.30B | 0.10% | 12,274 | - |
| 41 | ORKA | Oruka Therapeutics, Inc. | 6.30B | -1.50% | 13,385 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.30B | -0.45% | 9,793 | 306.90M |
| 43 | IMVT | Immunovant, Inc. | 6.15B | 0.40% | 5,870 | - |
| 44 | BLTE | Belite Bio, Inc | 6.08B | 0.41% | 10,055 | - |
| 45 | MANE | Veradermics, Incorporated | 5.96B | -0.84% | 8,023 | - |
| 46 | CGON | CG Oncology, Inc. | 5.61B | -0.32% | 39,191 | 6.23M |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | -0.79% | 18,621 | 618.07M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.55B | - | 11,161 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.39B | 0.25% | 49,122 | 1.16B |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.27B | -2.01% | 5,652 | - |
| 51 | ERAS | Erasca, Inc. | 5.26B | 0.47% | 146,116 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.22B | -0.55% | 63,973 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.00B | -2.03% | 23,325 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.86B | 1.94% | 25,371 | 591.33M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.58B | -1.06% | 9,209 | 1.90M |
| 56 | LEGN | Legend Biotech Corporation | 4.27B | -1.17% | 28,356 | 1.27B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | 0.80% | 10,542 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.19B | -1.69% | 32,228 | 10.35M |
| 59 | ABCL | AbCellera Biologics Inc. | 4.14B | -2.29% | 185,170 | 66.17M |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 4.02B | 0.16% | 43,334 | 463.98M |
| 61 | IOVA | Iovance Biotherapeutics, Inc. | 4.00B | -7.74% | 2,021,811 | 324.97M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.79B | -0.13% | 50,523 | 53.81M |
| 63 | IRON | Disc Medicine, Inc. | 3.68B | - | 10,027 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.63B | -0.11% | 11,194 | 7.50M |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.62B | 1.16% | 98,676 | 1.14B |
| 66 | PBLS | Parabilis Medicines, Inc. | 3.54B | -0.23% | 2,860 | 148.00K |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.43B | 0.26% | 102,509 | - |
| 68 | CELC | Celcuity Inc. | 3.36B | -0.77% | 6,740 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 0.08% | 11,157 | 606.33M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.25B | -1.64% | 5,387 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.18B | - | 33,217 | - |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | - | 20,949 | 234.13M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.08B | -0.36% | 10,898 | 3.60M |
| 74 | TLX | Telix Pharmaceuticals Limited | 3.04B | -3.26% | 11,515 | 890.79M |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.94B | -0.87% | 27,962 | 701.94M |
| 76 | BEAM | Beam Therapeutics Inc. | 2.87B | -0.24% | 44,568 | 156.04M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -0.20% | 15,168 | 71.13M |
| 78 | ZLAB | Zai Lab Limited | 2.77B | -0.34% | 31,835 | 449.61M |
| 79 | MBX | MBX Biosciences, Inc. | 2.70B | 2.68% | 3,396 | - |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.68B | 0.27% | 18,327 | 117.00M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.67B | 1.28% | 42,132 | 512.28M |
| 82 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | -1.37% | 5,759 | 7.12M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.43B | -4.25% | 960,054 | 54.86M |
| 84 | BHVN | Biohaven Ltd. | 2.42B | -2.67% | 70,838 | - |
| 85 | PGEN | Precigen, Inc. | 2.38B | 0.15% | 133,568 | 85.72M |
| 86 | PHVS | Pharvaris N.V. | 2.36B | - | 6,005 | - |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.35B | - | 10,885 | 158.00K |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 0.31% | 6,149 | 959.90M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | -1.63% | 68,109 | 311.51M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.22B | 0.92% | 14,048 | - |
| 91 | VCEL | Vericel Corporation | 2.20B | - | 2,210 | 306.30M |
| 92 | FTRE | Fortrea Holdings Inc. | 2.19B | -1.99% | 32,256 | 2.67B |
| 93 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -0.58% | 6,793 | - |
| 94 | XNCR | Xencor, Inc. | 2.17B | -0.24% | 15,323 | 104.97M |
| 95 | SEPN | Septerna, Inc. | 2.15B | 1.99% | 1,805 | 98.88M |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.15B | -2.13% | 51,049 | 208.78M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 2.08B | 0.65% | 6,692 | 1.13B |
| 98 | ZYME | Zymeworks Inc. | 2.06B | 0.91% | 15,127 | 37.13M |
| 99 | MESO | Mesoblast Limited | 2.04B | -1.21% | 16,282 | 120.25M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 2.04B | 0.42% | 28,139 | 1.97B |
| 101 | ABSI | Absci Corporation | 2.01B | -3.06% | 360,992 | 1.56M |
| 102 | IMNM | Immunome, Inc. | 2.01B | -3.17% | 80,901 | 4.02M |
| 103 | ADRX | ADARx Pharmaceuticals, Inc. | 2.00B | - | 1,915 | 6.13M |
| 104 | GENB | Generate Biomedicines, Inc. | 1.97B | -2.54% | 79,044 | 26.48M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.97B | - | 16,330 | - |
| 106 | VIR | Vir Biotechnology, Inc. | 1.97B | -1.11% | 20,558 | 303.23M |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | 1.83% | 1,537 | - |
| 108 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | -14.24% | 169,839 | 98.34M |
| 109 | SLS | SELLAS Life Sciences Group, Inc. | 1.90B | -7.14% | 526,519 | - |
| 110 | TRAX | First Tracks Biotherapeutics, Inc. | 1.90B | 0.18% | 2,806 | - |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.87B | - | 5,224 | 1.00M |
| 112 | MLYS | Mineralys Therapeutics, Inc. | 1.83B | -2.38% | 29,624 | - |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -1.97% | 85,413 | 59.51M |
| 114 | MAZE | Maze Therapeutics, Inc. | 1.74B | 0.78% | 7,015 | 20.00M |
| 115 | QURE | uniQure N.V. | 1.73B | -1.19% | 49,386 | 18.67M |
| 116 | NVAX | Novavax, Inc. | 1.73B | - | 124,776 | 413.80M |
| 117 | REPL | Replimune Group, Inc. | 1.70B | 3.22% | 77,755 | - |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.70B | - | 12,703 | 28.21M |
| 119 | KLRA | Kailera Therapeutics, Inc. | 1.69B | -2.76% | 3,811 | - |
| 120 | NUVB | Nuvation Bio Inc. | 1.67B | - | 13,275 | 169.90M |
| 121 | NBTX | Nanobiotix S.A. | 1.65B | -3.82% | 9,910 | 13.15M |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | 0.12% | 40,361 | 717.00M |
| 123 | BRVE | Braveheart Bio, Inc. | 1.62B | -6.21% | 1,309 | - |
| 124 | URGN | UroGen Pharma Ltd. | 1.62B | -1.19% | 13,911 | 188.73M |
| 125 | OCUL | Ocular Therapeutix, Inc. | 1.61B | 0.27% | 40,262 | 52.06M |
| 126 | LYCA | Lycia Therapeutics, Inc. | 1.60B | - | 249 | 4.44M |
| 127 | IMCR | Immunocore Holdings plc | 1.56B | -3.10% | 9,414 | 430.78M |
| 128 | GPCR | Structure Therapeutics Inc. | 1.54B | -1.32% | 10,461 | - |
| 129 | INVA | Innoviva, Inc. | 1.54B | - | 7,891 | 440.00M |
| 130 | GHRS | GH Research PLC | 1.51B | 2.00% | 1,830 | - |
| 131 | TYRA | Tyra Biosciences, Inc. | 1.46B | -1.30% | 15,472 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.44B | -1.09% | 14,373 | 106.09M |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.38B | - | 40 | - |
| 134 | OMER | Omeros Corporation | 1.38B | 0.26% | 27,561 | 38.42M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.36B | - | 884 | - |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | -1.90% | 10,947 | 5.49M |
| 137 | NKTR | Nektar Therapeutics | 1.33B | -0.46% | 11,574 | 54.59M |
| 138 | KARD | Kardigan, Inc. | 1.32B | -1.12% | 2,413 | - |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.30B | - | 2,675 | - |
| 140 | SNDX | Syndax Pharmaceuticals, Inc. | 1.25B | -0.78% | 39,357 | 252.25M |
| 141 | SVRA | Savara Inc. | 1.25B | -0.61% | 31,194 | - |
| 142 | AAPG | Ascentage Pharma Group International | 1.24B | -2.69% | 2,066 | 94.61M |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.20B | -2.12% | 23,324 | - |
| 144 | SLN | Silence Therapeutics plc | 1.19B | - | 15,648 | 615.00K |
| 145 | VSTM | Verastem, Inc. | 1.19B | 1.24% | 17,721 | 87.53M |
| 146 | VOR | Vor Biopharma Inc. | 1.19B | -3.97% | 52,990 | - |
| 147 | RAPP | Rapport Therapeutics, Inc. | 1.17B | 0.87% | 18,777 | 20.00M |
| 148 | MNKD | MannKind Corporation | 1.15B | 2.00% | 18,034 | 393.63M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.14B | -0.08% | 2,568 | - |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.13B | - | 8,124 | - |
| 151 | CTY | City Therapeutics, Inc. | 1.10B | - | 949 | 14.34M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 1.41% | 3,766 | 1.30M |
| 153 | SGP | SpyGlass Pharma, Inc. | 1.09B | - | 1,587 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.08B | 0.95% | 5,476 | - |
| 155 | JANX | Janux Therapeutics, Inc. | 1.04B | -4.37% | 13,362 | 24.00M |
| 156 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | - | 2,314 | - |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 999.75M | 0.55% | 15,341 | - |
| 158 | IMTX | Immatics N.V. | 999.20M | - | 1,625 | 47.65M |
| 159 | RIGL | Rigel Pharmaceuticals, Inc. | 971.35M | 1.07% | 14,868 | 276.79M |
| 160 | ODTX | Odyssey Therapeutics, Inc. | 950.22M | - | 1,685 | 99.00K |
| 161 | AKTS | Aktis Oncology, Inc. | 948.87M | 1.25% | 1,777 | 10.06M |
| 162 | KURA | Kura Oncology, Inc. | 936.76M | -0.28% | 23,895 | 77.23M |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 932.87M | 0.11% | 15,941 | - |
| 164 | MGTX | MeiraGTx Holdings plc | 932.10M | - | 4,345 | 397.50M |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 926.50M | -0.09% | 18,828 | 28.73M |
| 166 | ANRO | Alto Neuroscience, Inc. | 921.01M | - | 5,094 | - |
| 167 | PRME | Prime Medicine, Inc. | 909.09M | -2.48% | 208,999 | 4.07M |
| 168 | OBX | Obsidian Therapeutics, Inc. | 896.94M | - | 6,452 | - |
| 169 | JBIO | Jade Biosciences, Inc. | 896.72M | -0.98% | 29,165 | - |
| 170 | ALMS | Alumis Inc. | 890.51M | -0.15% | 16,040 | 7.40M |
| 171 | IVA | Inventiva S.A. | 877.66M | -0.54% | 190,021 | 2.81M |
| 172 | CRVS | Corvus Pharmaceuticals, Inc. | 855.93M | -0.54% | 7,089 | - |
| 173 | PHAR | Pharming Group N.V. | 854.21M | - | 250 | 386.75M |
| 174 | ABUS | Arbutus Biopharma Corporation | 846.79M | - | 135,780 | 181.72M |
| 175 | DNA | Ginkgo Bioworks Holdings, Inc. | 814.82M | -5.02% | 61,437 | 132.42M |
| 176 | SANA | Sana Biotechnology, Inc. | 805.28M | -1.10% | 27,734 | - |
| 177 | AVBP | ArriVent BioPharma, Inc. | 790.40M | 0.50% | 34,522 | - |
| 178 | ANNX | Annexon, Inc. | 777.54M | 2.28% | 56,695 | - |
| 179 | ARDX | Ardelyx, Inc. | 768.74M | -0.48% | 69,273 | 450.89M |
| 180 | HELP | Helus Pharma Inc. | 760.58M | -2.80% | 89,837 | - |
| 181 | WVE | Wave Life Sciences, Inc. | 743.55M | 3.86% | 34,711 | 70.92M |
| 182 | ACHV | Achieve Life Sciences, Inc. | 739.87M | - | 11,883 | - |
| 183 | SGMT | Sagimet Biosciences Inc. | 737.45M | -0.29% | 27,507 | - |
| 184 | ATTO | Attovia Therapeutics, Inc. | 726.31M | 4.19% | 7,855 | 1.80M |
| 185 | APMD | Apnimed, Inc. | 707.72M | -1.96% | 11,857 | 115.12M |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 706.02M | - | 4,784 | 92.01M |
| 187 | DSGN | Design Therapeutics, Inc. | 692.15M | - | 7,344 | - |
| 188 | SLDB | Solid Biosciences Inc. | 679.81M | -0.78% | 3,881 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 679.68M | - | 3,561 | 109.82M |
| 190 | OABI | OmniAb, Inc. | 678.97M | -10.71% | 160,464 | 38.46M |
| 191 | IMMX | Immix Biopharma, Inc. | 674.00M | 1.88% | 19,980 | - |
| 192 | SLBT | SL Science Holding Limited | 667.21M | - | 102 | 3.27M |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 662.98M | 0.68% | 18,005 | 41.47M |
| 194 | ANL | Adlai Nortye Group Ltd. | 662.01M | - | 518 | 18.06M |
| 195 | CADL | Candel Therapeutics, Inc. | 658.06M | -0.58% | 8,929 | - |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | - | 15,377 | - |
| 197 | AURA | Aura Biosciences, Inc. | 638.82M | -2.14% | 5,989 | - |
| 198 | IAM | Iambic Therapeutics, Inc. | 619.05M | -8.54% | 27,129 | 18.25M |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 616.84M | -0.25% | 44,510 | 8.22M |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 615.22M | - | 3,974 | 136.07M |
| 201 | NVCT | Nuvectis Pharma, Inc. | 610.58M | 0.92% | 2,676 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 598.17M | -0.67% | 2,985 | 11.88M |
| 203 | BCAX | Bicara Therapeutics Inc. | 595.56M | -7.50% | 102,966 | - |
| 204 | CLYM | Climb Bio, Inc. | 592.74M | -0.10% | 30,227 | - |
| 205 | GERN | Geron Corporation | 584.59M | -3.84% | 597,417 | 204.56M |
| 206 | DBVT | DBV Technologies S.A. | 582.58M | -3.11% | 17,780 | 3.76M |
| 207 | NGNE | Neurogene Inc. | 576.73M | - | 957 | 925.00K |
| 208 | MDXG | MiMedx Group, Inc. | 574.22M | -0.88% | 25,396 | 303.73M |
| 209 | STTK | Shattuck Labs, Inc. | 574.08M | - | 3,079 | 1.00M |
| 210 | DRUG | Bright Minds Biosciences Inc. | 559.97M | - | 209 | - |
| 211 | ENTX | Entera Bio Ltd. | 554.92M | 2.26% | 1,625 | 42.00K |
| 212 | ETRA | Electra Therapeutics, Inc. | 542.31M | - | 297 | - |
| 213 | PBYI | Puma Biotechnology, Inc. | 542.01M | -0.38% | 5,192 | 231.24M |
| 214 | VALN | Valneva SE | 541.61M | - | 838 | 163.30M |
| 215 | INDP | Indaptus Therapeutics, Inc. | 528.32M | 2.99% | 4,510 | - |
| 216 | CRMD | CorMedix Inc. | 527.68M | -11.39% | 183,958 | 462.25M |
| 217 | ARVN | Arvinas, Inc. | 515.24M | -0.25% | 15,349 | 316.70M |
| 218 | SRZN | Surrozen, Inc. | 513.40M | -0.39% | 659 | 11.51M |
| 219 | DMAC | DiaMedica Therapeutics Inc. | 513.37M | - | 5,271 | - |
| 220 | OCS | Oculis Holding AG | 508.67M | - | 1,861 | 1.45M |
| 221 | OVID | Ovid Therapeutics Inc. | 507.77M | 1.56% | 15,416 | 1.58M |
| 222 | CTMX | CytomX Therapeutics, Inc. | 501.17M | 0.44% | 129,877 | 18.30M |
| 223 | PHAT | Phathom Pharmaceuticals, Inc. | 494.06M | - | 27,373 | 274.88M |
| 224 | RGNX | REGENXBIO Inc. | 492.46M | 0.67% | 25,291 | 174.48M |
| 225 | FTH | Faeth Therapeutics, Inc. | 485.80M | 0.27% | 4,037 | - |
| 226 | BLSM | BlossomHill Therapeutics, Inc. | 483.45M | - | 3,653 | - |
| 227 | MNPR | Monopar Therapeutics Inc. | 482.67M | - | 862 | - |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 477.93M | - | 469 | - |
| 229 | PRTA | Prothena Corporation plc | 455.87M | - | 9,382 | 54.53M |
| 230 | EDIT | Editas Medicine, Inc. | 446.15M | -0.85% | 26,496 | 47.01M |
| 231 | PROK | ProKidney Corp. | 433.83M | -2.38% | 33,053 | 818.00K |
| 232 | RZLT | Rezolute, Inc. | 432.17M | - | 3,146 | - |
| 233 | ALLO | Allogene Therapeutics, Inc. | 431.86M | - | 91,722 | 4.64M |
| 234 | MPLT | MapLight Therapeutics, Inc. | 430.16M | 0.26% | 2,339 | - |
| 235 | ASMB | Assembly Biosciences, Inc. | 424.72M | - | 929 | 74.85M |
| 236 | AUTL | Autolus Therapeutics plc | 417.88M | -0.63% | 46,606 | 117.39M |
| 237 | YDES | YD Bio Limited | 415.78M | - | 491 | 1.24M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 415.07M | -1.71% | 1,391 | 22.42M |
| 239 | ALT | Altimmune, Inc. | 412.38M | -0.93% | 75,416 | 31.00K |
| 240 | CCCC | C4 Therapeutics, Inc. | 411.52M | 1.36% | 37,291 | 35.04M |
| 241 | TECX | Tectonic Therapeutic, Inc. | 402.72M | 0.49% | 5,090 | - |
| 242 | FENC | Fennec Pharmaceuticals Inc. | 383.99M | - | 400 | 59.22M |
| 243 | AVTX | Avalo Therapeutics, Inc. | 380.77M | -4.57% | 16,327 | 59.00K |
| 244 | NAUT | Nautilus Biotechnology, Inc. | 379.57M | -5.10% | 490,053 | 424.00K |
| 245 | CAPR | Capricor Therapeutics, Inc. | 377.90M | -1.96% | 132,937 | 11.13M |
| 246 | ZURA | Zura Bio Limited | 369.89M | -0.26% | 55,203 | - |
| 247 | RLMD | Relmada Therapeutics, Inc. | 366.94M | - | 2,168 | - |
| 248 | OBIO | Orchestra BioMed Holdings, Inc. | 366.04M | - | 1,382 | 31.98M |
| 249 | TRXB | TRex Bio, Inc. | 360.75M | -0.89% | 1,603 | - |
| 250 | SPRY | ARS Pharmaceuticals, Inc. | 358.01M | -1.64% | 36,005 | 116.93M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 355.90M | -1.63% | 6,400 | - |
| 252 | GALT | Galectin Therapeutics Inc. | 354.99M | - | 767 | - |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 345.68M | - | 2,190 | - |
| 254 | CTNM | Contineum Therapeutics, Inc. | 339.72M | -3.22% | 8,189 | - |
| 255 | AGMB | AgomAb Therapeutics NV | 329.96M | -15.72% | 29,554 | - |
| 256 | VTVT | vTv Therapeutics Inc. | 327.77M | - | 15 | 36.84M |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 327.18M | -1.79% | 8,745 | 15.85M |
| 258 | ARCT | Arcturus Therapeutics Holdings Inc. | 326.58M | -5.43% | 11,941 | 29.37M |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 321.11M | -1.12% | 3,364 | 65.26M |
| 260 | ALEC | Alector, Inc. | 320.40M | -3.52% | 17,620 | 13.86M |
| 261 | SCTX | Scribe Therapeutics Inc. | 319.95M | -3.10% | 15,143 | 33.30M |
| 262 | AGEN | Agenus Inc. | 319.19M | - | 16,906 | 132.69M |
| 263 | BNTC | Benitec Biopharma Inc. | 308.01M | - | 1,037 | - |
| 264 | SABS | SAB Biotherapeutics, Inc. | 306.62M | 4.33% | 1,802 | 114.70K |
| 265 | IKT | Inhibikase Therapeutics, Inc. | 302.24M | -0.60% | 4,285 | 1.00 |
| 266 | TTRX | Turn Therapeutics Inc. | 298.18M | -6.62% | 667 | - |
| 267 | IRD | Opus Genetics, Inc. | 297.20M | -2.13% | 10,459 | 9.86M |
| 268 | VOGX | Vogenx, Inc. | 295.91M | - | 464 | - |
| 269 | EIKN | Eikon Therapeutics, Inc. | 289.78M | - | 8,330 | - |
| 270 | FULC | Fulcrum Therapeutics, Inc. | 284.59M | -1.06% | 11,862 | 80.00M |
| 271 | VCRE | Vicore Pharma Holding AB (publ) | 282.71M | - | 1 | 412.09K |
| 272 | LYEL | Lyell Immunopharma, Inc. | 277.03M | - | 842 | 27.00K |
| 273 | LRMR | Larimar Therapeutics, Inc. | 275.57M | -1.12% | 14,814 | - |
| 274 | RCKT | Rocket Pharmaceuticals, Inc. | 275.53M | -1.18% | 10,123 | - |
| 275 | BCYC | Bicycle Therapeutics plc | 267.37M | - | 1,731 | 83.53M |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 264.82M | 1.66% | 10,341 | 13.08M |
| 277 | CABA | Cabaletta Bio, Inc. | 264.49M | -1.58% | 40,903 | - |
| 278 | QTTB | Q32 Bio Inc. | 263.91M | -0.06% | 4,624 | 53.74M |
| 279 | GLSI | Greenwich LifeSciences, Inc. | 263.33M | -5.58% | 3,035 | - |
| 280 | IPSC | Century Therapeutics, Inc. | 260.75M | -1.37% | 2,003 | 109.16M |
| 281 | IMRX | Immuneering Corporation | 260.73M | 0.25% | 47,514 | - |
| 282 | FATE | Fate Therapeutics, Inc. | 258.81M | -0.46% | 4,256 | 6.49M |
| 283 | ABEO | Abeona Therapeutics Inc. | 258.19M | -0.99% | 12,490 | 25.52M |
| 284 | CUVL | Clinuvel Pharmaceuticals Limited | 256.24M | - | - | 65.05M |
| 285 | IFRX | InflaRx N.V. | 253.47M | 0.29% | 9,710 | -11.54K |
| 286 | OCGN | Ocugen, Inc. | 252.64M | 0.11% | 128,450 | 4.58M |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 245.48M | 0.25% | 24,632 | 229.28M |
| 288 | LXEO | Lexeo Therapeutics, Inc. | 245.31M | -2.29% | 36,598 | - |
| 289 | ELDN | Eledon Pharmaceuticals, Inc. | 244.84M | -0.99% | 22,896 | - |
| 290 | CAMP | Camp4 Therapeutics Corporation | 244.74M | - | 743 | 4.22M |
| 291 | EVMN | Evommune, Inc. | 242.98M | -1.69% | 11,972 | 10.00M |
| 292 | ACIU | AC Immune SA | 235.64M | - | 596 | 21.67M |
| 293 | PYXS | Pyxis Oncology, Inc. | 225.81M | 0.02% | 3,505 | 11.04M |
| 294 | KROS | Keros Therapeutics, Inc. | 225.24M | - | 458 | 15.01M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 224.79M | - | 662 | 1.80M |
| 296 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 214.07M | -1.11% | 3,939 | - |
| 297 | KRRO | Korro Bio, Inc. | 209.10M | - | 1,459 | 2.38M |
| 298 | PLX | Protalix BioTherapeutics, Inc. | 207.77M | -1.20% | 4,575 | 80.62M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 204.22M | - | 266 | 1.48M |
| 300 | DTIL | Precision BioSciences, Inc. | 202.87M | -1.21% | 2,142 | 45.06M |
| 301 | ARTV | Artiva Biotherapeutics, Inc. | 202.41M | -2.13% | 99,914 | 251.00K |
| 302 | PALI | Palisade Bio, Inc. | 201.28M | -2.94% | 66,897 | 500.00K |
| 303 | ACOG | Alpha Cognition Inc. | 200.36M | 0.11% | 193 | 15.26M |
| 304 | PRQR | ProQR Therapeutics N.V. | 199.69M | -1.74% | 5,587 | 21.05M |
| 305 | CGEN | Compugen Ltd. | 189.45M | -1.96% | 4,301 | 74.00M |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 188.13M | - | 314 | 7.15M |
| 307 | ZNTL | Zentalis Pharmaceuticals, Inc. | 186.50M | -1.01% | 50,346 | 26.87M |
| 308 | YARW | Yarrow Bioscience, Inc. | 186.09M | - | 616 | - |
| 309 | SION | Sionna Therapeutics, Inc. | 180.85M | - | 3,378 | - |
| 310 | MDWD | MediWound Ltd. | 178.94M | - | 1,130 | 11.86M |
| 311 | UPB | Upstream Bio, Inc. | 178.55M | -0.31% | 8,308 | 3.16M |
| 312 | ADAG | Adagene Inc. | 176.59M | -1.87% | 1,475 | 9.29M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 175.96M | - | 1,412 | 2.00M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 173.96M | -1.71% | 3,439 | - |
| 315 | PEPG | PepGen Inc. | 171.07M | 2.49% | 7,204 | - |
| 316 | ALXO | ALX Oncology Holdings Inc. | 168.70M | - | 13,729 | - |
| 317 | IVVD | Invivyd, Inc. | 167.42M | -5.65% | 111,348 | 58.37M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 163.35M | - | 43,104 | 1.50M |
| 319 | TRDA | Entrada Therapeutics, Inc. | 158.65M | - | 1,395 | 4.69M |
| 320 | VRXA | Veraxa Biotech AG | 158.45M | -0.84% | 16,613 | 29.54K |
| 321 | CUE | Cue Biopharma, Inc. | 155.82M | - | 1,327 | 37.66M |
| 322 | NGEN | NervGen Pharma Corp. | 153.76M | -0.69% | 41,621 | - |
| 323 | STRO | Sutro Biopharma, Inc. | 151.55M | - | 2,525 | 45.70M |
| 324 | TARA | Protara Therapeutics, Inc. | 147.74M | -0.79% | 9,471 | - |
| 325 | MSLE | Satellos Bioscience Inc. | 145.66M | - | 41 | - |
| 326 | MGNX | MacroGenics, Inc. | 142.05M | -6.30% | 4,361 | 175.14M |
| 327 | RNA | Atrium Therapeutics, Inc. | 141.29M | - | 14,726 | 35.84M |
| 328 | NBP | NovaBridge Biosciences | 140.36M | - | 6,225 | - |
| 329 | MENS | Jyong Biotech Ltd. | 139.56M | - | 805 | - |
| 330 | CHRS | Coherus Oncology, Inc. | 139.05M | 0.18% | 41,227 | 50.94M |
| 331 | MOLN | Molecular Partners AG | 138.60M | - | 15 | 856.30K |
| 332 | CMPX | Compass Therapeutics, Inc. | 135.37M | -0.60% | 87,993 | 850.00K |
| 333 | SPRB | Spruce Biosciences, Inc. | 134.56M | - | 207 | 697.00K |
| 334 | IPHA | Innate Pharma S.A. | 134.53M | - | 17 | 11.21M |
| 335 | CDXS | Codexis, Inc. | 133.60M | - | 6,249 | 77.68M |
| 336 | HURA | TuHURA Biosciences, Inc. | 129.37M | -1.46% | 3,956 | - |
| 337 | FHTX | Foghorn Therapeutics Inc. | 124.12M | - | 1,055 | 36.74M |
| 338 | HUMA | Humacyte, Inc. | 119.56M | -8.39% | 168,186 | 2.12M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 119.36M | -0.65% | 209,249 | -1.16M |
| 340 | ARMP | Armata Pharmaceuticals, Inc. | 118.98M | -1.54% | 7,013 | 5.54M |
| 341 | AVXL | Anavex Life Sciences Corp. | 118.83M | -1.39% | 19,190 | - |
| 342 | NKTX | Nkarta, Inc. | 118.54M | -0.30% | 39,740 | - |
| 343 | TLSA | Tiziana Life Sciences Ltd | 117.53M | 1.47% | 1,214 | - |
| 344 | KZIA | Kazia Therapeutics Limited | 116.48M | -2.52% | 4,371 | 1.27M |
| 345 | PYPD | PolyPid Ltd. | 113.34M | -0.18% | 5,152 | - |
| 346 | EQ | Equillium, Inc. | 111.28M | - | 6,411 | 4.39M |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 111.19M | -3.38% | 7,057,156 | 3.39M |
| 348 | PDSB | PDS Biotechnology Corporation | 110.89M | -1.29% | 495,004 | - |
| 349 | MIST | Milestone Pharmaceuticals Inc. | 109.88M | -1.24% | 14,203 | 2.34M |
| 350 | ANIX | Anixa Biosciences, Inc. | 109.51M | -4.55% | 13,310 | - |
| 351 | VYGR | Voyager Therapeutics, Inc. | 108.45M | - | 5,193 | 34.46M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 108.01M | 1.08% | 6,414 | 70.00M |
| 353 | NERV | Minerva Neurosciences, Inc. | 106.95M | - | 242 | - |
| 354 | LENZ | LENZ Therapeutics, Inc. | 106.83M | -2.58% | 11,672 | 12.36M |
| 355 | OKUR | OnKure Therapeutics, Inc. | 106.10M | - | 4,658 | - |
| 356 | IMUX | Immunic, Inc. | 105.20M | -1.09% | 9,196 | - |
| 357 | UNCY | Unicycive Therapeutics, Inc. | 105.01M | -1.05% | 11,081 | - |
| 358 | TENX | Tenax Therapeutics, Inc. | 104.83M | -1.61% | 21,001 | - |
| 359 | CBUS | Cibus, Inc. | 103.18M | - | 1,467 | 4.35M |
| 360 | VANI | Vivani Medical, Inc. | 102.83M | - | 763 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 101.86M | -0.65% | 3,457 | - |
| 362 | RTSN | Retension Pharmaceuticals, Inc. | 98.56M | - | 339 | - |
| 363 | PMVP | PMV Pharmaceuticals, Inc. | 98.17M | -3.70% | 18,303 | - |
| 364 | SEER | Seer, Inc. | 97.45M | -9.28% | 44,977 | 14.22M |
| 365 | TVGN | Tevogen Inc. | 95.21M | - | 203 | - |
| 366 | NRXS | NeurAxis, Inc. | 94.81M | - | 217 | 5.32M |
| 367 | GNLX | Genelux Corporation | 94.11M | - | 6,678 | 8.00K |
| 368 | ICCC | ImmuCell Corporation | 93.73M | - | 275 | 30.68M |
| 369 | COYA | Coya Therapeutics, Inc. | 93.36M | - | 1,019 | 8.02M |
| 370 | PLYX | Polaryx Therapeutics, Inc. | 92.71M | - | 136 | - |
| 371 | CLLS | Cellectis S.A. | 89.44M | - | 1,123 | 63.82M |
| 372 | TNYA | Tenaya Therapeutics, Inc. | 88.62M | -0.80% | 67,694 | 1.34M |
| 373 | TNXP | Tonix Pharmaceuticals Holding Corp. | 88.59M | -2.18% | 12,735 | 29.10M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 85.62M | - | 151 | 6.19M |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 85.52M | 7.17% | 4,389,756 | 65.34K |
| 376 | CNXU | Conexeu Sciences Inc. | 84.63M | -3.00% | 13,260 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 83.64M | -0.89% | 14,385 | 4.88M |
| 378 | RLYB | Rallybio Corporation | 82.79M | 1.17% | 3,840 | 434.00K |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 81.62M | - | 4,248 | - |
| 380 | NTRB | Nutriband Inc. | 80.71M | - | 219 | 1.62M |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 80.04M | 3.21% | - | 39.99K |
| 382 | PMN | ProMIS Neurosciences, Inc. | 78.92M | -20.58% | 18,214 | - |
| 383 | OKYO | OKYO Pharma Limited | 78.72M | - | 1,255 | - |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 75.85M | 0.57% | 1,540 | - |
| 385 | CING | Cingulate Inc. | 74.02M | -1.93% | 717 | - |
| 386 | NMRA | Neumora Therapeutics, Inc. | 71.40M | -2.14% | 43,762 | - |
| 387 | TELO | Telomir Pharmaceuticals, Inc. | 70.98M | - | 1,164 | - |
| 388 | CRDF | Cardiff Oncology, Inc. | 70.95M | - | 5,436 | 508.00K |
| 389 | MAIA | MAIA Biotechnology, Inc. | 70.56M | -1.69% | 5,792 | - |
| 390 | RNXT | RenovoRx, Inc. | 69.50M | 3.36% | 9,676 | 1.98M |
| 391 | MNOV | MediciNova, Inc. | 68.42M | -0.71% | 867 | 920.48K |
| 392 | PTHS | Pelthos Therapeutics Inc. | 68.38M | 7.98% | 15,455 | 43.30M |
| 393 | CSBR | Champions Oncology, Inc. | 66.95M | - | 19 | 60.66M |
| 394 | CGTX | Cognition Therapeutics, Inc. | 66.57M | -5.33% | 21,951 | - |
| 395 | FBIO | Fortress Biotech, Inc. | 65.11M | -2.38% | 4,778 | 68.47M |
| 396 | GOSS | Gossamer Bio, Inc. | 64.93M | -0.70% | 4,812 | 53.29M |
| 397 | SPRO | Spero Therapeutics, Inc. | 64.64M | - | 429 | 47.00M |
| 398 | RNTX | Rein Therapeutics Inc. | 62.68M | - | 39 | - |
| 399 | XBIT | XBiotech Inc. | 60.67M | 2.58% | 455 | - |
| 400 | VRCA | Verrica Pharmaceuticals Inc. | 59.95M | 2.05% | 650 | 30.32M |
| 401 | OSTX | OS Therapies Incorporated | 58.22M | -3.08% | 26,377 | - |
| 402 | HRTX | Heron Therapeutics, Inc. | 57.37M | 2.65% | 14,967 | 151.18M |
| 403 | BOLD | Boundless Bio, Inc. | 56.66M | 0.45% | 413 | - |
| 404 | HYFT | MindWalk Holdings Corp. | 56.53M | - | 5,370 | 11.57M |
| 405 | ONCY | Oncolytics Biotech Inc. | 55.72M | 2.17% | 42,577 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 55.50M | - | 289 | - |
| 407 | CLNN | Clene Inc. | 55.01M | -0.77% | 1,736 | 197.00K |
| 408 | CNTB | Connect Biopharma Holdings Limited | 54.15M | 2.93% | 25,738 | 2.95M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 54.00M | 1.40% | 1,848 | - |
| 410 | IBIO | iBio, Inc. | 53.70M | 2.63% | 7,381 | 100.00K |
| 411 | ALPS | Alps Group Inc | 53.41M | -1.20% | 3,033 | 3.74M |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.28M | - | 50 | - |
| 413 | GANX | Gain Therapeutics, Inc. | 51.94M | - | 601 | - |
| 414 | HOWL | Werewolf Therapeutics, Inc. | 51.52M | -3.64% | 12,152 | 21.00M |
| 415 | XLO | Xilio Therapeutics, Inc. | 51.13M | - | - | 64.09M |
| 416 | KLRS | Kalaris Therapeutics, Inc. | 50.70M | - | 184 | - |
| 417 | HYPD | Hyperion DeFi, Inc. | 49.73M | -8.70% | 11,728 | 1.40M |
| 418 | INMB | INmune Bio Inc. | 49.21M | - | 4,322 | 50.00K |
| 419 | CRBU | Caribou Biosciences, Inc. | 48.94M | 2.58% | 21,589 | 10.04M |
| 420 | MREO | Mereo BioPharma Group plc | 48.87M | 1.39% | 8,422 | 500.00K |
| 421 | ATNM | Actinium Pharmaceuticals, Inc. | 48.42M | 0.65% | 12,097 | 35.09M |
| 422 | BMEA | Biomea Fusion, Inc. | 46.69M | 3.42% | 30,708 | - |
| 423 | APLM | Apollomics, Inc. | 46.45M | 1.68% | 4 | 8.84M |
| 424 | TIL | Instil Bio, Inc. | 46.29M | - | 902 | - |
| 425 | LONA | LeonaBio, Inc. | 45.32M | -2.04% | 855 | - |
| 426 | ELTX | Elicio Therapeutics, Inc. | 45.20M | -1.71% | 7,885 | - |
| 427 | IMA | ImageneBio, Inc. | 44.84M | -2.47% | 6 | 800.00K |
| 428 | SER | Serina Therapeutics, Inc. | 44.45M | -7.41% | 4,819 | 130.00K |
| 429 | ANVS | Annovis Bio, Inc. | 43.46M | - | 19,800 | - |
| 430 | ATHE | Alterity Therapeutics Limited | 42.73M | - | 391 | 2.50M |
| 431 | DWTX | Dogwood Therapeutics, Inc. | 41.81M | - | 5,139 | - |
| 432 | ACET | Adicet Bio, Inc. | 40.26M | 4.47% | 5,448 | - |
| 433 | GRCE | Grace Therapeutics, Inc. | 39.96M | -2.07% | 2,114 | - |
| 434 | ALDX | Aldeyra Therapeutics, Inc. | 39.66M | -0.24% | 11,985 | - |
| 435 | GRDX | GridAI Technologies Corp. | 38.59M | - | 310 | - |
| 436 | VERU | Veru Inc. | 38.36M | 0.90% | 5,269 | 16.89M |
| 437 | EXOZ | eXoZymes, Inc. | 38.15M | - | 2 | -700.00 |
| 438 | EDSA | Edesa Biotech, Inc. | 36.48M | - | 339 | - |
| 439 | NNVC | NanoViricides, Inc. | 35.48M | -2.80% | 7,339 | - |
| 440 | LITS | Lite Strategy, Inc. | 33.45M | -5.98% | 118,881 | - |
| 441 | IBO | Impact BioMedical Inc. | 33.06M | - | 66 | 35.00K |
| 442 | EYPT | EyePoint, Inc. | 32.20M | -1.71% | 204,952 | 2.79M |
| 443 | IRLA | IRulya Therapeutics Inc. | 32.16M | - | 4,328 | - |
| 444 | FLNA | Filana Therapeutics, Inc. | 31.61M | -0.57% | 11,540 | - |
| 445 | AARD | Aardvark Therapeutics, Inc. | 31.51M | - | 49,107 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 31.41M | - | 114 | 31.52M |
| 447 | ESLA | Estrella Immunopharma, Inc. | 30.64M | -3.32% | 6,370 | - |
| 448 | MGX | Metagenomi Therapeutics, Inc. | 30.26M | -3.52% | 33,627 | 13.56M |
| 449 | NXTC | NextCure, Inc. | 29.87M | - | 67 | - |
| 450 | RNAZ | TransCode Therapeutics, Inc. | 29.29M | - | 3,869 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 28.84M | -0.30% | 8,615 | - |
| 452 | ABVC | ABVC BioPharma, Inc. | 27.00M | - | 1,849 | 797.92K |
| 453 | CELU | Celularity Inc. | 26.94M | -2.26% | 907 | 18.67M |
| 454 | CVM | CEL-SCI Corporation | 26.79M | 1.53% | 9,615 | - |
| 455 | CRVO | CervoMed Inc. | 26.00M | -1.71% | 23,711 | 331.30K |
| 456 | EVAX | Evaxion A/S | 25.82M | 0.51% | 625 | 7.49M |
| 457 | ABOS | Acumen Pharmaceuticals, Inc. | 24.49M | -85.77% | 15,205,232 | - |
| 458 | IMMP | Immutep Limited | 23.86M | - | 1,194 | 13.79M |
| 459 | BSEM | BioStem Technologies, Inc. | 23.23M | -3.10% | 6,667 | 34.59M |
| 460 | ATOS | Atossa Therapeutics, Inc. | 22.25M | - | 273 | - |
| 461 | PLRZ | Polyrizon Ltd. | 21.87M | - | 5,178 | - |
| 462 | QNTM | Quantum BioPharma Ltd. | 21.34M | 3.28% | 3,991 | - |
| 463 | BYSI | BeyondSpring Inc. | 20.22M | -4.82% | 3,692 | 1.88M |
| 464 | IGC | IGC Pharma, Inc. | 20.16M | -2.11% | 42,109 | 1.11M |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.94M | - | 108 | - |
| 466 | ACTU | Actuate Therapeutics, Inc. | 19.80M | -2.96% | 27,963 | - |
| 467 | KPTI | Karyopharm Therapeutics Inc. | 19.74M | -1.10% | 182,783 | 146.62M |
| 468 | MCRB | Seres Therapeutics, Inc. | 19.59M | - | 835 | 1.88M |
| 469 | CNTX | Context Therapeutics Inc. | 19.29M | 4.07% | 58,780 | - |
| 470 | KYNB | Kyntra Bio, Inc. | 18.83M | - | 420 | 4.62M |
| 471 | AKTX | Akari Therapeutics, Plc | 18.28M | - | 72 | - |
| 472 | COCP | Cocrystal Pharma, Inc. | 17.84M | -5.51% | 757 | 330.00K |
| 473 | JSPR | Jasper Therapeutics, Inc. | 17.32M | -2.16% | 17,613 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 16.84M | - | 3,987 | 3.55M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 16.56M | - | 8,659 | 1.17M |
| 476 | NCEL | NewcelX Ltd. | 15.55M | - | 2,109 | - |
| 477 | CTXR | Citius Pharmaceuticals, Inc. | 15.35M | -0.73% | 5,355 | 7.11M |
| 478 | PLUR | Pluri Inc. | 14.81M | - | 266 | 1.02M |
| 479 | BCDA | BioCardia, Inc. | 13.93M | -0.65% | 1,242 | 3.00K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 13.84M | -2.24% | 44,927 | 345.00K |
| 481 | AEON | AEON Biopharma, Inc. | 13.79M | -5.99% | 52,266 | - |
| 482 | PBM | Psyence Biomedical Ltd. | 13.39M | -2.77% | 1,888 | - |
| 483 | DARE | Daré Bioscience, Inc. | 13.34M | -0.51% | 436,257 | 1.37M |
| 484 | TCRX | TScan Therapeutics, Inc. | 13.27M | 0.46% | 6,813 | 7.11M |
| 485 | CNSY | Cerenome, Inc. | 13.21M | - | 470 | 4.20M |
| 486 | DYAI | Dyadic International, Inc. | 13.12M | -0.28% | 1,302 | 3.80M |
| 487 | ATYR | aTyr Pharma, Inc. | 12.82M | -2.61% | 4,704 | 190.00K |
| 488 | ADIL | Adial Pharmaceuticals, Inc. | 12.74M | -3.96% | - | - |
| 489 | GUTS | Fractyl Health, Inc. | 12.47M | -5.19% | 33,241 | 3.00K |
| 490 | HIND | Vyome Holdings, Inc. | 12.42M | 1.14% | 560 | 129.73K |
| 491 | ICU | SeaStar Medical Holding Corporation | 12.36M | 1.73% | 3,479 | 1.71M |
| 492 | KTTA | Pasithea Therapeutics Corp. | 12.35M | - | 535 | - |
| 493 | BOLT | Bolt Biotherapeutics, Inc. | 12.12M | -1.10% | 6,573 | 4.70M |
| 494 | LPCN | Lipocine Inc. | 12.06M | -3.74% | 7,273 | 1.57M |
| 495 | CALC | CalciMedica, Inc. | 11.96M | 0.09% | 1,466 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 11.95M | 9.58% | 2,140 | - |
| 497 | RADX | Radiopharm Theranostics Limited | 11.48M | -5.95% | - | 8.90M |
| 498 | KPRX | Kiora Pharmaceuticals, Inc. | 11.45M | 2.27% | 3,151 | 20.00K |
| 499 | TVRD | Tvardi Therapeutics, Inc. | 11.34M | -1.49% | 5,228 | - |
| 500 | PASG | Passage Bio, Inc. | 11.33M | - | 104 | - |